ETHAMOLIN Drug Patent Profile
✉ Email this page to a colleague
When do Ethamolin patents expire, and when can generic versions of Ethamolin launch?
Ethamolin is a drug marketed by Qol Medcl and is included in one NDA.
The generic ingredient in ETHAMOLIN is ethanolamine oleate. There are eighteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ethanolamine oleate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ETHAMOLIN?
- What are the global sales for ETHAMOLIN?
- What is Average Wholesale Price for ETHAMOLIN?
Summary for ETHAMOLIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 18 |
Clinical Trials: | 1 |
Patent Applications: | 510 |
What excipients (inactive ingredients) are in ETHAMOLIN? | ETHAMOLIN excipients list |
DailyMed Link: | ETHAMOLIN at DailyMed |
Recent Clinical Trials for ETHAMOLIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
M.D. Anderson Cancer Center | Phase 1/Phase 2 |
National Cancer Institute (NCI) | Phase 1/Phase 2 |
Pharmacology for ETHAMOLIN
Drug Class | Sclerosing Agent |
Mechanism of Action | Sclerosing Activity |
Physiological Effect | Vascular Sclerosing Activity |
US Patents and Regulatory Information for ETHAMOLIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Qol Medcl | ETHAMOLIN | ethanolamine oleate | INJECTABLE;INJECTION | 019357-001 | Dec 22, 1988 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |